20 August 2025
The Biotech Growth Trust PLC
(the "Company")
Capital Reduction
The Company announces that on 19 August 2025, The High Court of Justice
confirmed the cancellation of the sums standing to the credit of the Company's
share premium account and the capital redemption reserve, and conversion of
the amount so cancelled to a distributable reserve (the "Capital Reduction").
The Capital Reduction will become effective on registration of the Court Order
at Companies House.
The purpose of the Capital Reduction is to provide the Company with a
significant pool of reserves which can be used in the future, if required, to
fund share buybacks or other returns of capital in accordance with applicable
law. The cancellation will therefore provide the Company with more flexibility
in how capital may be returned in the future.
For further information, please contact:
Katherine Manson
Frostrow Capital LLP, Company Secretary
Telephone: 020 3709 8734
Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved